secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0001140361-22-035194
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem SVP & GM James Hyde to retire upon successor appointment; transition through 2023
--------------------------------------------------------------------------------

- James C. Hyde, SVP and General Manager of Human Nutrition & Health, notified company of retirement.
- He will step down when successor is appointed and stay for transition, retiring in 2023.
- No material changes to Hyde's compensatory arrangement as a result of the planned retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000114036122035194/0001140361-22-035194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000114036122035194/brhc10042360_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-035194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer